About our product

DISCLAIMER: THIS PAGE IS INTENDED FOR MEMBERS OF THE GENERAL PUBLIC IN PORTUGAL ONLY.

The information provided on this site is intended for general information and education for Portugal-based members of the public and is not intended to be a substitute for the advice provided by a physician or other qualified healthcare professional.

Nuvaxovid▼ dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

Important information
For more information about the NuvaxovidTM COVID-19 Vaccine (recombinant, adjuvanted), view the PDF file of the Product Information Leaflet.

If you have any questions or concerns regarding NuvaxovidTM COVID-19 Vaccine (recombinant, adjuvanted), please speak to your healthcare professional.

Summary of Product Characteristics (SmPC)

This link below will allow you to download/view the PDF SmPC document.

Summary of Product Characteristics (SmPC)
Patient information leaflet (PL)

This link below will allow you to download/view the PL document.

View Patient information leaflet (PL)